SkyAI, Inc. Common Stock (SKYA) Stock Price, News & Analysis

Company Overview

Sharps Technology (NASDAQ:STSS) is an insurtech company specializing in technology-enabled subrogation recovery services for property and casualty insurers. The company’s flagship platform combines process automation, data analytics and digital workflow tools to help carriers and third-party administrators identify, manage and recover funds from liable third parties. By streamlining the subrogation lifecycle—from claim intake through recovery—Sharps delivers greater transparency, faster turnaround times and improved recovery rates for its clients.

Since its initial public offering in late 2021, Sharps Technology has focused on expanding its presence across the United States. Headquartered in Chicago, the company partners with regional and national insurers to integrate its platform into existing claims systems, ensuring compliance with industry regulations and data security standards. Sharps also offers customizable reporting and performance-tracking dashboards, enabling clients to monitor key metrics and drive continuous process improvements.

The Sharps leadership team brings together professionals with deep experience in insurance technology, claims management and legal services. Guided by a board with backgrounds in both traditional insurance and emerging insurtech markets, the company continues to invest in research and development aimed at enhancing automation capabilities, refining analytics models and broadening its suite of recovery solutions within the casualty insurance sector.

Key Stats

• Today's Range: $1.43 to $1.65
• 50-Day Range: $1.07 to $2.09
• 52-Week Range: $1.42 to $18.23
• Volume: 295,886 shs
• Average Volume: 231,997 shs
• Market Capitalization: $60.94 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

SkyAI, Inc. Common Stock Stock Analysis - MarketRank™

SkyAI, Inc. Common Stock scored higher than 17% of companies evaluated by MarketBeat, and ranked 824th out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

SkyAI, Inc. Common Stock has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

SkyAI, Inc. Common Stock has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

SkyAI, Inc. Common Stock has a P/B Ratio of 0.16. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.41% of the float of SkyAI, Inc. Common Stock has been sold short.

Short Interest Ratio / Days to Cover

SkyAI, Inc. Common Stock has a short interest ratio ("days to cover") of 1.97, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in SkyAI, Inc. Common Stock has recently decreased by 1.25%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

SkyAI, Inc. Common Stock does not currently pay a dividend.

Dividend Growth

SkyAI, Inc. Common Stock does not have a long track record of dividend growth.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 0.62

News Sentiment

SkyAI, Inc. Common Stock has a news sentiment score of 0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for SkyAI, Inc. Common Stock this week, compared to 2 articles on an average week.

Search Interest

4 people have searched for SKYA on MarketBeat in the last 30 days.

Company Ownership

• Score: 0.2 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, SkyAI, Inc. Common Stock insiders have not sold or bought any company stock.

Percentage Held by Insiders

1.22% of the stock of SkyAI, Inc. Common Stock is held by insiders.

Percentage Held by Institutions

17.17% of the stock of SkyAI, Inc. Common Stock is held by institutions.

Company Calendar

• Last Earnings: 5/14/2026
• Today: 6/02/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:SKYA
• Previous Symbol: NASDAQ:STSS
• CIK: 1737995
• Web: www.theskyai.co
• Phone: 631-574-4436
• Fax: N/A
• Employees: 55
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$282.50 million
• Net Margins: N/A
• Pretax Margin: -205,990.44%
• Return on Equity: -157.91%
• Return on Assets: -154.40%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 8.28
• Quick Ratio: 8.08

Sales & Book Value

• Annual Sales: $200 thousand
• Price / Sales: 304.70
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $9.12 per share
• Price / Book: 0.16

Miscellaneous

• Outstanding Shares: 42,320,000
• Free Float: 41,806,000
• Market Cap: $60.94 million
• Optionable: Not Optionable
• Beta: 2.04